279 related articles for article (PubMed ID: 21172433)
21. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
22. Adiponectin decreases pyruvate dehydrogenase kinase 4 gene expression in obese- and diabetic-derived myotubes.
McAinch AJ; Cameron-Smith D
Diabetes Obes Metab; 2009 Jul; 11(7):721-8. PubMed ID: 19527483
[TBL] [Abstract][Full Text] [Related]
23. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
24. Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans.
Banerjee J; Bruckbauer A; Zemel MB
Metabolism; 2016 Nov; 65(11):1679-1691. PubMed ID: 27456392
[TBL] [Abstract][Full Text] [Related]
25. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
Kase ET; Feng YZ; Badin PM; Bakke SS; Laurens C; Coue M; Langin D; Gaster M; Thoresen GH; Rustan AC; Moro C
Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
[TBL] [Abstract][Full Text] [Related]
26. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
27. Lipid-induced insulin resistance is prevented in lean and obese myotubes by AICAR treatment.
Bikman BT; Zheng D; Reed MA; Hickner RC; Houmard JA; Dohm GL
Am J Physiol Regul Integr Comp Physiol; 2010 Jun; 298(6):R1692-9. PubMed ID: 20393162
[TBL] [Abstract][Full Text] [Related]
28. Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.
Cha BS; Ciaraldi TP; Park KS; Carter L; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E151-9. PubMed ID: 15727952
[TBL] [Abstract][Full Text] [Related]
29. Yhhu981, a novel compound, stimulates fatty acid oxidation via the activation of AMPK and ameliorates lipid metabolism disorder in ob/ob mice.
Zeng HL; Huang SL; Xie FC; Zeng LM; Hu YH; Leng Y
Acta Pharmacol Sin; 2015 Mar; 36(3):343-52. PubMed ID: 25732571
[TBL] [Abstract][Full Text] [Related]
30. Primary defects in lipid handling and resistance to exercise in myotubes from obese donors with and without type 2 diabetes.
Løvsletten NG; Rustan AC; Laurens C; Thoresen GH; Moro C; Nikolić N
Appl Physiol Nutr Metab; 2020 Feb; 45(2):169-179. PubMed ID: 31276628
[TBL] [Abstract][Full Text] [Related]
31. AICAR stimulates mitochondrial biogenesis and BCAA catabolic enzyme expression in C2C12 myotubes.
Hinkle JS; Rivera CN; Vaughan RA
Biochimie; 2022 Apr; 195():77-85. PubMed ID: 34798200
[TBL] [Abstract][Full Text] [Related]
32. Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle.
Teodoro BG; Sampaio IH; Bomfim LH; Queiroz AL; Silveira LR; Souza AO; Fernandes AM; Eberlin MN; Huang TY; Zheng D; Neufer PD; Cortright RN; Alberici LC
J Physiol; 2017 Feb; 595(3):677-693. PubMed ID: 27647415
[TBL] [Abstract][Full Text] [Related]
33. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics.
Chen MB; McAinch AJ; Macaulay SL; Castelli LA; O'brien PE; Dixon JB; Cameron-Smith D; Kemp BE; Steinberg GR
J Clin Endocrinol Metab; 2005 Jun; 90(6):3665-72. PubMed ID: 15769985
[TBL] [Abstract][Full Text] [Related]
34. Effects of Icariin on insulin resistance via the activation of AMPK pathway in C2C12 mouse muscle cells.
Han Y; Jung HW; Park YK
Eur J Pharmacol; 2015 Jul; 758():60-3. PubMed ID: 25840280
[TBL] [Abstract][Full Text] [Related]
35. Reduced incorporation of fatty acids into triacylglycerol in myotubes from obese individuals with type 2 diabetes.
Sparks LM; Bosma M; Brouwers B; van de Weijer T; Bilet L; Schaart G; Moonen-Kornips E; Eichmann TO; Lass A; Hesselink MKC; Schrauwen P
Diabetes; 2014 May; 63(5):1583-1593. PubMed ID: 24487026
[TBL] [Abstract][Full Text] [Related]
36. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects.
Gaster M; Beck-Nielsen H
Biochim Biophys Acta; 2006 Jan; 1761(1):100-10. PubMed ID: 16442843
[TBL] [Abstract][Full Text] [Related]
37. AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells.
Lv Q; Zhen Q; Liu L; Gao R; Yang S; Zhou H; Goswami R; Li Q
Life Sci; 2015 Jun; 131():23-9. PubMed ID: 25817233
[TBL] [Abstract][Full Text] [Related]
38. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
39. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.
Dzamko N; Schertzer JD; Ryall JG; Steel R; Macaulay SL; Wee S; Chen ZP; Michell BJ; Oakhill JS; Watt MJ; Jørgensen SB; Lynch GS; Kemp BE; Steinberg GR
J Physiol; 2008 Dec; 586(23):5819-31. PubMed ID: 18845612
[TBL] [Abstract][Full Text] [Related]
40. Palmitate activates mTOR/p70S6K through AMPK inhibition and hypophosphorylation of raptor in skeletal muscle cells: Reversal by oleate is similar to metformin.
Kwon B; Querfurth HW
Biochimie; 2015 Nov; 118():141-50. PubMed ID: 26344902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
